|
|
| Research article summary (published 30 Mar 2006): |
Effect of institutional smoking prohibition on Japanese inpatients with chronic schizophrenia.
Full Abstract
OBJECTIVE:
A higher prevalence of smoking among schizophrenic patients has been well documented in Japan and other countries. Smoking reduction or cessation is desirable to reduce various physical complications in schizophrenic patients, but the effect of smoking reduction on psychiatric status and BMI remains ambiguous. The aim of this study was to determine the effect of an institutional smoking prohibition on smoking status, psychiatric status and BMI in Japanese inpatients with schizophrenia.
METHOD:
Smoking status, psychiatric status (Clinical Global Impression (CGI) scores:
global severity score and global change score) and BMI were investigated in 256 chronic schizophrenic inpatients before and 3 months after prohibition of smoking in a Japanese psychiatric hospital building.
RESULTS:
Following prohibition, the smoking rate decreased from 36.3% to 22.2%. A weak positive correlation was found between decreased cigarette consumption and the CGI global change score (r=0.140, p=0.025), but the mean global change scores in the smoking groups were less than 6 (minimally worse). No significant increase in BMI was observed.
CONCLUSION:
Institutional smoking prohibition is effective in reducing the smoking rate, while having only a minor unfavorable effect on psychiatric status and BMI in chronic schizophrenic inpatients.
Learn Faster Today Improve your study skills
Author information
Author/s: Kitabayashi, Yurinosuke (Y); Narumoto, Jin (J); Shibata, Keisuke (K); Nakamae, Takashi (T); Kamei, Junko (J); Sano, Kumi (K); Oka, Shogo (S); Yamashita, Tatsuhisa (T); Kitabayashi, Masaki (M); Fukui, Kenji (K);
Affiliation: Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan.
Journal and publication information
Publication Type: Journal Article
Journal: Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence (Nihon Arukoru Yakubutsu Igakkai Zasshi), published in Japan. (Language: eng)
Reference: 2006-Apr; vol 41 (issue 2) : pp 128-33
Dates: Created 2006/05/31; Completed 2006/08/04;
PMID: 16734280, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia.
18 Jun 2008 - High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.
3 Mar 2008 - Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
16 Apr 2008 - [Psychosis and chronic delirium]
27 Feb 2008 - Elevated nailfold plexus visibility aggregates in families and is associated with a specific negative symptom pattern in schizophrenia.
31 May 2008 - Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia.
30 May 2008 - Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
29 Jun 2008 - Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
30 May 2008 - Socioeconomic deprivation and extended hospitalization in severe mental disorder: a two-year follow-up study.
28 Feb 2008 - Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia.
28 Feb 2008
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.